InnoCare Announces First Pediatric Patient Dosed in Clinical Trial of pan-TRK Inhibitor Zurletrectinib in China
BEIJING--(BUSINESS WIRE)--InnoCare Pharma (HKEX: 09969; SSE: 688428), a leading biopharmaceutical company focusing on the treatment of cancer and autoimmune diseases,...

Chase wins toss, West Indies 69/3 on day one as WI look to seal series vs Bangladesh in Sylhet
PFC declares ₹4.10 second interim dividend as standalone Q2 PAT rises 11.76%
West Indies Capitalise on Dhaka Dominance as Bangladesh Fight for Survival in Sylhet
Brown’s late block lifts 76ers past Pistons as LeBron makes 16,000 mark
Chinese tape maker Crown New Materials surges 787% in Shenzhen debut, creating paper billionaires 




























